Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Boeing's 2025–26 Revenue Outlook Post Q4 23 Earnings

Published 01/30/2024, 02:43 PM
Updated 07/09/2023, 06:31 AM

It’s hard to think of a more out-of-favor stock coming into Q4 ’23 earnings season than Boeing (BA), with Boeing Co (NYSE:BA) is scheduled to report their calendar Q4 ’23 financial results before the opening bell on Wednesday, January 31 ’24. Even if the EPS estimate of a loss of ($0.78) and the revenue estimate of $21.1 billion are beaten, much will depend on the conference call, and order cancellations (if any) and whether the original ’25 – ’26 cash-flow and production story is still intact.

Let’s look at Boeing’s EPS and estimate revisions:

Earning Estimates
Earning Estimates
Personally, I think BA’s earnings estimates are meaningless here given the losses in 2023, and while 2024 EPS estimates are still expected to be positive, the 2024 EPS estimate has lost more than half its value in the last 12 – 14 months.

What might be worth focusing on is BA’s revenue estimates and revisions for ’24 – ’26 since the changes will tell us the degree of order cancellations for BA planes, and whether the headlines and the press coverage is far more dire than the reality of the situation.

Note how even after the Alaska Air (NYSE:ALK) fiasco and press coverage, the 2024 revenue estimate remains in the $100 ml range the last 4 months, and the 2025 revenue estimate has ticked slightly higher.

That data being said, it’s small consolation.

Boeing summary / conclusion: 

The ramp in the BA’s stock from November 1 around $180 to the end of 2023’s $260 print, was truly remarkable to behold, and then Alaska Air door flying off mid-flight, and the other mid-flight incidences, caused investors to think, “same old Boeing” much like Detroit Lions fans lamented after Sunday’s NFC Championship.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

There are appears to be good support for the stock in the $200 area, which is the area of the 200-week moving average, although that average looks wobbly, as it’s pointing lower, so how the stock trades after earnings tomorrow, relative to the headlines and management commentary will matter much.

Boeing’s undeniable strength is it’s competitive position and the oligopolistic nature of the aircraft manufacturing industry. There are only three companies capable of BA’s manufacturing prowess of producing 50 planes a month, and those are Airbus and COMAC, which is the Chinese competitor, and I’m not sure Comac is a viable alternative to either of Boeing or AirBus.

Another positive for BA’s prospects is that according to a trusted corporate bond manager source, Boeing’s corporate credits aren’t showing any duress or unusual trading pressure as of this week, even with the latest news.

Boeing was always going to be a ’25 – ’26 cash-flow story per the Street consensus and per the conference call notes from Q3 ’23, the goal for BA was to be on track to produce 50 planes a month by ’25 – ’26, so the first thing to watch is to see if there is a material change to that production schedule tomorrow. Let’s see how ’25 – ’26 revenue estimates change – if at all – after tomorrow’s earnings release.

Like Tesla (NASDAQ:TSLA) last week, it’s hard to think of a worse media and sentiment environment within which Boeing will report earnings, so the calculation is how much of the endless string of bad news is discounted in the stock price, versus how many airlines can or will cancel forward airline orders.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Morningstar Inc (NASDAQ:MORN) has a fair value on the stock of $232 and quantifies the manufacturing defects at between $1 – and $32 per share, which would leave the new fair value at $200 or where the stock is trading today, under a worst-case scenario.

Clients have a 1.5% – 1.6% position in the stock, and this position will likely be held until after earnings are seen tomorrow morning, and the research has been vetted.

Boeing is a “play the long game” stock, particularly in a market being driven by the mega-caps and the high end of the S&P 500. It’s tough to buy a stock like this in front of earnings, given the unknowns, and what else may be disclosed.

Clients are long a 1.5% position in the stock and it will be held at least until Q4 ’23 results are seen and digested.

None of this is advice or a recommendation. Past performance is no guarantee or suggestion of future results. Investing can involve the loss of principal. Earnings releases can trigger bigger moves in a stock price, both up and down, so be careful about buying stocks in front of earnings. Readers should gauge your own appetite with market volatility and adjust your portfolio accordingly.

Latest comments

Landing gear failure, door flying off mid flight of a new jet and other loose bolts found in other planes . These are not insignificant they are jugular potentially devastating issues that the current team owns and apparently incapable of mitigating!
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.